- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- FUL: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-FUL.2: 5 residues within 4Å:- Chain A: N.106, N.188, K.190, S.191, K.476
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.190, A:R.219, A:N.188, A:K.190
- Water bridges: A:T.108, A:N.106
- Hydrophobic interactions: A:N.106
NAG-FUL.16: 5 residues within 4Å:- Chain B: N.106, N.188, K.190, S.191, K.476
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:K.190, B:R.219, B:N.188, B:K.190
- Water bridges: B:T.108, B:N.106
- Hydrophobic interactions: B:N.106
NAG-FUL.30: 5 residues within 4Å:- Chain C: N.106, N.188, K.190, S.191, K.476
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:K.190, C:R.219, C:N.188, C:K.190
- Water bridges: C:T.108, C:N.106
- Hydrophobic interactions: C:N.106
NAG-FUL.44: 5 residues within 4Å:- Chain D: N.106, N.188, K.190, S.191, K.476
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:K.190, D:R.219, D:N.188, D:K.190
- Water bridges: D:T.108, D:N.106
- Hydrophobic interactions: D:N.106
NAG-FUL.58: 5 residues within 4Å:- Chain E: N.106, N.188, K.190, S.191, K.476
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:K.190, E:R.219, E:N.188, E:K.190
- Water bridges: E:T.108, E:N.106
- Hydrophobic interactions: E:N.106
NAG-FUL.72: 5 residues within 4Å:- Chain F: N.106, N.188, K.190, S.191, K.476
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:K.190, F:R.219, F:N.188, F:K.190
- Water bridges: F:T.108, F:N.106
- Hydrophobic interactions: F:N.106
NAG-FUL.86: 5 residues within 4Å:- Chain G: N.106, N.188, K.190, S.191, K.476
4 PLIP interactions:4 interactions with chain G- Hydrogen bonds: G:K.190, G:R.219, G:N.188, G:K.190
- Water bridges: G:T.108, G:N.106
- Hydrophobic interactions: G:N.106
NAG-FUL.100: 5 residues within 4Å:- Chain H: N.106, N.188, K.190, S.191, K.476
4 PLIP interactions:4 interactions with chain H- Hydrogen bonds: H:K.190, H:R.219, H:N.188, H:K.190
- Water bridges: H:T.108, H:N.106
- Hydrophobic interactions: H:N.106
- 8 x TC3: ETHYL HYDROGEN METHYLAMIDOPHOSPHATE(Covalent)
TC3.4: 10 residues within 4Å:- Chain A: G.115, G.116, G.117, S.198, A.199, W.231, L.286, V.288, F.398, H.438
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.231, A:L.286, A:V.288
- Hydrogen bonds: A:G.116, A:G.117, A:A.199, A:H.438
TC3.18: 10 residues within 4Å:- Chain B: G.115, G.116, G.117, S.198, A.199, W.231, L.286, V.288, F.398, H.438
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:W.231, B:L.286, B:V.288
- Hydrogen bonds: B:G.116, B:G.117, B:A.199, B:H.438
TC3.32: 10 residues within 4Å:- Chain C: G.115, G.116, G.117, S.198, A.199, W.231, L.286, V.288, F.398, H.438
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:W.231, C:L.286, C:V.288
- Hydrogen bonds: C:G.116, C:G.117, C:A.199, C:H.438
TC3.46: 10 residues within 4Å:- Chain D: G.115, G.116, G.117, S.198, A.199, W.231, L.286, V.288, F.398, H.438
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:W.231, D:L.286, D:V.288
- Hydrogen bonds: D:G.116, D:G.117, D:A.199, D:H.438
TC3.60: 10 residues within 4Å:- Chain E: G.115, G.116, G.117, S.198, A.199, W.231, L.286, V.288, F.398, H.438
7 PLIP interactions:7 interactions with chain E- Hydrophobic interactions: E:W.231, E:L.286, E:V.288
- Hydrogen bonds: E:G.116, E:G.117, E:A.199, E:H.438
TC3.74: 10 residues within 4Å:- Chain F: G.115, G.116, G.117, S.198, A.199, W.231, L.286, V.288, F.398, H.438
7 PLIP interactions:7 interactions with chain F- Hydrophobic interactions: F:W.231, F:L.286, F:V.288
- Hydrogen bonds: F:G.116, F:G.117, F:A.199, F:H.438
TC3.88: 10 residues within 4Å:- Chain G: G.115, G.116, G.117, S.198, A.199, W.231, L.286, V.288, F.398, H.438
7 PLIP interactions:7 interactions with chain G- Hydrophobic interactions: G:W.231, G:L.286, G:V.288
- Hydrogen bonds: G:G.116, G:G.117, G:A.199, G:H.438
TC3.102: 10 residues within 4Å:- Chain H: G.115, G.116, G.117, S.198, A.199, W.231, L.286, V.288, F.398, H.438
7 PLIP interactions:7 interactions with chain H- Hydrophobic interactions: H:W.231, H:L.286, H:V.288
- Hydrogen bonds: H:G.116, H:G.117, H:A.199, H:H.438
- 8 x NA: SODIUM ION(Non-functional Binders)
NA.5: 3 residues within 4Å:- Chain A: F.525
- Chain D: F.525
- Ligands: NA.47
No protein-ligand interaction detected (PLIP)NA.19: 3 residues within 4Å:- Chain B: F.525
- Chain C: F.525
- Ligands: NA.33
No protein-ligand interaction detected (PLIP)NA.33: 3 residues within 4Å:- Chain B: F.525
- Chain C: F.525
- Ligands: NA.19
No protein-ligand interaction detected (PLIP)NA.47: 3 residues within 4Å:- Chain A: F.525
- Chain D: F.525
- Ligands: NA.5
No protein-ligand interaction detected (PLIP)NA.61: 3 residues within 4Å:- Chain E: F.525
- Chain H: F.525
- Ligands: NA.103
No protein-ligand interaction detected (PLIP)NA.75: 3 residues within 4Å:- Chain F: F.525
- Chain G: F.525
- Ligands: NA.89
No protein-ligand interaction detected (PLIP)NA.89: 3 residues within 4Å:- Chain F: F.525
- Chain G: F.525
- Ligands: NA.75
No protein-ligand interaction detected (PLIP)NA.103: 3 residues within 4Å:- Chain E: F.525
- Chain H: F.525
- Ligands: NA.61
No protein-ligand interaction detected (PLIP)- 16 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 4 residues within 4Å:- Chain A: K.323, Y.420, R.515
- Ligands: CL.9
Ligand excluded by PLIPSO4.10: 4 residues within 4Å:- Chain A: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain B: K.323, Y.420, R.515
- Ligands: CL.23
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain B: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain C: K.323, Y.420, R.515
- Ligands: CL.37
Ligand excluded by PLIPSO4.38: 4 residues within 4Å:- Chain C: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.48: 4 residues within 4Å:- Chain D: K.323, Y.420, R.515
- Ligands: CL.51
Ligand excluded by PLIPSO4.52: 4 residues within 4Å:- Chain D: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.62: 4 residues within 4Å:- Chain E: K.323, Y.420, R.515
- Ligands: CL.65
Ligand excluded by PLIPSO4.66: 4 residues within 4Å:- Chain E: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.76: 4 residues within 4Å:- Chain F: K.323, Y.420, R.515
- Ligands: CL.79
Ligand excluded by PLIPSO4.80: 4 residues within 4Å:- Chain F: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.90: 4 residues within 4Å:- Chain G: K.323, Y.420, R.515
- Ligands: CL.93
Ligand excluded by PLIPSO4.94: 4 residues within 4Å:- Chain G: Q.316, G.413, N.414, N.415
Ligand excluded by PLIPSO4.104: 4 residues within 4Å:- Chain H: K.323, Y.420, R.515
- Ligands: CL.107
Ligand excluded by PLIPSO4.108: 4 residues within 4Å:- Chain H: Q.316, G.413, N.414, N.415
Ligand excluded by PLIP- 32 x CL: CHLORIDE ION(Non-functional Binders)
CL.7: 2 residues within 4Å:- Chain A: H.77, H.126
Ligand excluded by PLIPCL.8: 3 residues within 4Å:- Chain A: D.378, Q.380, R.381
Ligand excluded by PLIPCL.9: 3 residues within 4Å:- Chain A: R.515
- Chain G: R.509
- Ligands: SO4.6
Ligand excluded by PLIPCL.11: 2 residues within 4Å:- Chain A: R.347, Q.351
Ligand excluded by PLIPCL.21: 2 residues within 4Å:- Chain B: H.77, H.126
Ligand excluded by PLIPCL.22: 3 residues within 4Å:- Chain B: D.378, Q.380, R.381
Ligand excluded by PLIPCL.23: 3 residues within 4Å:- Chain B: R.515
- Chain F: R.509
- Ligands: SO4.20
Ligand excluded by PLIPCL.25: 2 residues within 4Å:- Chain B: R.347, Q.351
Ligand excluded by PLIPCL.35: 2 residues within 4Å:- Chain C: H.77, H.126
Ligand excluded by PLIPCL.36: 3 residues within 4Å:- Chain C: D.378, Q.380, R.381
Ligand excluded by PLIPCL.37: 3 residues within 4Å:- Chain C: R.515
- Chain H: R.509
- Ligands: SO4.34
Ligand excluded by PLIPCL.39: 2 residues within 4Å:- Chain C: R.347, Q.351
Ligand excluded by PLIPCL.49: 2 residues within 4Å:- Chain D: H.77, H.126
Ligand excluded by PLIPCL.50: 3 residues within 4Å:- Chain D: D.378, Q.380, R.381
Ligand excluded by PLIPCL.51: 3 residues within 4Å:- Chain D: R.515
- Chain E: R.509
- Ligands: SO4.48
Ligand excluded by PLIPCL.53: 2 residues within 4Å:- Chain D: R.347, Q.351
Ligand excluded by PLIPCL.63: 2 residues within 4Å:- Chain E: H.77, H.126
Ligand excluded by PLIPCL.64: 3 residues within 4Å:- Chain E: D.378, Q.380, R.381
Ligand excluded by PLIPCL.65: 3 residues within 4Å:- Chain D: R.509
- Chain E: R.515
- Ligands: SO4.62
Ligand excluded by PLIPCL.67: 2 residues within 4Å:- Chain E: R.347, Q.351
Ligand excluded by PLIPCL.77: 2 residues within 4Å:- Chain F: H.77, H.126
Ligand excluded by PLIPCL.78: 3 residues within 4Å:- Chain F: D.378, Q.380, R.381
Ligand excluded by PLIPCL.79: 3 residues within 4Å:- Chain B: R.509
- Chain F: R.515
- Ligands: SO4.76
Ligand excluded by PLIPCL.81: 2 residues within 4Å:- Chain F: R.347, Q.351
Ligand excluded by PLIPCL.91: 2 residues within 4Å:- Chain G: H.77, H.126
Ligand excluded by PLIPCL.92: 3 residues within 4Å:- Chain G: D.378, Q.380, R.381
Ligand excluded by PLIPCL.93: 3 residues within 4Å:- Chain A: R.509
- Chain G: R.515
- Ligands: SO4.90
Ligand excluded by PLIPCL.95: 2 residues within 4Å:- Chain G: R.347, Q.351
Ligand excluded by PLIPCL.105: 2 residues within 4Å:- Chain H: H.77, H.126
Ligand excluded by PLIPCL.106: 3 residues within 4Å:- Chain H: D.378, Q.380, R.381
Ligand excluded by PLIPCL.107: 3 residues within 4Å:- Chain C: R.509
- Chain H: R.515
- Ligands: SO4.104
Ligand excluded by PLIPCL.109: 2 residues within 4Å:- Chain H: R.347, Q.351
Ligand excluded by PLIP- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 2 residues within 4Å:- Chain A: R.14, N.57
Ligand excluded by PLIPNAG.13: 4 residues within 4Å:- Chain A: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: N.256, E.259
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain B: R.14, N.57
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain B: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: N.256, E.259
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: R.14, N.57
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain C: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: N.256, E.259
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain D: R.14, N.57
Ligand excluded by PLIPNAG.55: 4 residues within 4Å:- Chain D: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain D: N.256, E.259
Ligand excluded by PLIPNAG.68: 2 residues within 4Å:- Chain E: R.14, N.57
Ligand excluded by PLIPNAG.69: 4 residues within 4Å:- Chain E: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.70: 2 residues within 4Å:- Chain E: N.256, E.259
Ligand excluded by PLIPNAG.82: 2 residues within 4Å:- Chain F: R.14, N.57
Ligand excluded by PLIPNAG.83: 4 residues within 4Å:- Chain F: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.84: 2 residues within 4Å:- Chain F: N.256, E.259
Ligand excluded by PLIPNAG.96: 2 residues within 4Å:- Chain G: R.14, N.57
Ligand excluded by PLIPNAG.97: 4 residues within 4Å:- Chain G: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.98: 2 residues within 4Å:- Chain G: N.256, E.259
Ligand excluded by PLIPNAG.110: 2 residues within 4Å:- Chain H: R.14, N.57
Ligand excluded by PLIPNAG.111: 4 residues within 4Å:- Chain H: R.465, K.469, E.482, N.485
Ligand excluded by PLIPNAG.112: 2 residues within 4Å:- Chain H: N.256, E.259
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Carletti, E. et al., Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun. Biochem. J. (2009)
- Release Date
- 2009-05-19
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-octamer
- Ligands
- 16 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- FUL: beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x TC3: ETHYL HYDROGEN METHYLAMIDOPHOSPHATE(Covalent)
- 8 x NA: SODIUM ION(Non-functional Binders)
- 16 x SO4: SULFATE ION(Non-functional Binders)
- 32 x CL: CHLORIDE ION(Non-functional Binders)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Carletti, E. et al., Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun. Biochem. J. (2009)
- Release Date
- 2009-05-19
- Peptides
- CHOLINESTERASE: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A